Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ELEVATE Early LEvosimendan Vs Usual Care in Advanced Chronic hearT failurE (ELEVATE)

This study has suspended participant recruitment.
(Due to lack of enrollment)
Sponsor:
Collaborator:
Orion Corporation, Orion Pharma
Information provided by (Responsible Party):
Niguarda Hospital
ClinicalTrials.gov Identifier:
NCT01290146
First received: February 3, 2011
Last updated: January 16, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)